Freestone Grove Partners’s Tenet Healthcare THC Stock Holding History

Freestone Grove Partners’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26M	Buy	138,923 +34,736	+33%	+$6.39M	0.17%	178
2026 Q1	$19.7M	Buy	+104,187	New	+$22M	0.14%	211
2025 Q4	–	Sell	-134,197	Closed	-$27.2M	–	941
2025 Q3	$27.2M	Sell	134,197 -93,833	-41%	-$16.6M	0.2%	168
2025 Q2	$40.1M	Sell	228,030 -49,468	-18%	-$7.45M	0.3%	125
2025 Q1	$37.3M	Buy	+277,498	New	+$36.5M	0.38%	86

Other funds holding THC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Freestone Grove Partners's THC Position: Q2 2026 in Review

Freestone Grove Partners increased its Tenet Healthcare (THC) stake by 33% in Q2 2026, buying an estimated $6.39M and bringing the position to 138,923 shares worth $26M. The position accounts for 0.17% of the portfolio, ranked #178.

Freestone Grove Partners first reported a position in THC in Q1 2025 and has held it in 5 quarters since. The position peaked at $40.1M in Q2 2025. 679 funds tracked by Wall St. Rank hold THC as of Q2 2026.

Freestone Grove Partners held 138,923 shares of Tenet Healthcare worth $26M as of Q2 2026.
Freestone Grove Partners bought 34,736 Tenet Healthcare shares in Q2 2026, an estimated $6.39M.
Tenet Healthcare made up 0.17% of Freestone Grove Partners's portfolio in Q2 2026, its #178 holding.
Freestone Grove Partners first reported a position in Tenet Healthcare in Q1 2025 and has held it in 5 quarters since.
Freestone Grove Partners's Tenet Healthcare position peaked at $40.1M in Q2 2025.
679 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.